Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
Immuno-Oncology
33 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
PAO-06-022-CL-04
Cell Therapy
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
PAO-06-022-CL-03
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
PAO-05-22-R250-09
Oncolytic Viruses
Coverting Viruses into Therapeutic Tools
PAO-04-22-R250-14
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
PR-M03-22-17
Anti-Cancer Therapeutic
“Amazing” Nanoparticles from Maize: A Potent and Economical Anti-Cancer Therapeutic
PR-M02-22-11
Immunotherapy Research
Genetically Engineered Dual Receptor T-cells: Double Trouble for Cancer Cells
PR-M01-22-23
Biotech-CDMO Relationship
For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record
PAO-09-21-CL-03
Immuno-Oncology
Training the Immune System to Recognize Cancer Cells
PTV-07-21-CL-001
Financing
Kahr Announces $46.5 Million Financing to Advance Its Multifunctional Immunotherapeutic Pipeline
PR-M06-21-021
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
PAO-01-21-CL-06
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
PAP-Q4-20-CL-005
Strategic Partnership
Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies
PR-M07-20-NI-021
Cancer Therapies
Computational Discoveries for Clinical Development of Novel Cancer Therapies
PAP-Q2-20-CL-014
Immunotherapy
Leveraging the Native Immune Response to Fight Cancer
PAP-Q2-20-CL-017
M&A
Sanofi to Acquire Synthorx to Bolster its Immuno-Oncology Pipeline for $2.5 Billion
PR-M12-19-NI-016
CAR-T
Leveraging Natural Killer Cells as CAR-T Therapies
PAP-Q4-19-CL-013
Immuno-oncology Startup
Polsky Center for Entrepreneurship and Innovation Supports University of Chicago Professor in Founding Immuno-oncology Startup
PR-M07-19-NI-047
M&A
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
Immune Markers
Using Immune Markers to Identify Precancerous Cells
PAO-M06-19-NI-015
Oncology
Cancer’s New Foes—Novel Oncology Approaches in the Battle Against Cancer
PAP-Q2-2019-CL-020
Immuno-Oncology
Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-Oncology Symposium
PR-M03-19-NI-006
Immuno-Oncology
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
PR-M02-19-NI-067
Immuno-Oncology
The Immuno-Oncology Assays Market is Expected to Grow From USD 2.9 Billion in 2018 to USD 5.9 Billion by 2024, at a CAGR of 12.7%
PR-M02-19-NI-053
1
2
»
